Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Michael Steffens
Affiliation
Federal Institute for Drugs and Medical Devices (BfArM)
ORCID
Career Start Year
2005
Papers
77
H Index
32
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
34905151
Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe.
Mol Diagn Ther
2022
35923707
Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes.
Front Genet
2022
35102241
Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes.
Pharmacogenomics J
2022
34025403
CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED Study.
Front Pharmacol
2021
33516672
Fall-Associated Drugs in Community-Dwelling Older Adults: Results from the ActiFE Ulm Study.
J Am Med Dir Assoc
2021
34012511
Association between miRNA signatures in serum samples from epidermal growth factor inhibitor treated patients and skin toxicity.
Oncotarget
2021
34206978
Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe.
Diagnostics (Basel)
2021
32345696
Influence of metabolic profiles on the safety of drug therapy in routine care in Germany: protocol of the cohort study EMPAR.
BMJ Open
2020
31832731
Personalising drug safety-results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED).
Eur J Clin Pharmacol
2020
32106330
Prevalence of Psychotropic Drugs in Cases of Severe Adverse Drug Reactions Leading to Unplanned Emergency Visits in General Hospitals.
Pharmacopsychiatry
2020
33121145
Impact of Zika Virus Infection on Human Neural Stem Cell MicroRNA Signatures.
Viruses
2020
32612257
Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients.
Transl Psychiatry
2020
32250457
The phenotype of adverse drug effects: Do emergency visits due to adverse drug reactions look different in older people? Results from the ADRED study.
Br J Clin Pharmacol
2020
32152378
Signals of anticipation of reward and of mean reward rates in the human brain.
Sci Rep
2020
32527038
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED Study.
J Clin Med
2020
31274544
A serotonin transporter polymorphism is associated with postoperative nausea and vomiting: An observational study in two different patient cohorts.
Eur J Anaesthesiol
2019
31734534
Interferon-beta-induced changes in neuroimaging phenotypes of appetitive motivation and reactivity to emotional salience.
Neuroimage Clin
2019
28747224
Regions of common inter-individual DNA methylation differences in human monocytes: genetic basis and potential function.
Epigenetics Chromatin
2017
28456787
Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash.
Oncotarget
2017
28291260
Gene expression and proliferation biomarkers for antidepressant treatment resistance.
Transl Psychiatry
2017
28669097
Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
Eur J Clin Pharmacol
2017
27112273
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
BMC Fam Pract
2016
26392368
Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.
Behav Genet
2016
27845776
Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy.
Transl Psychiatry
2016
27541716
Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption.
Pain
2016
26820683
Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash.
Eur J Cancer
2016
27054571
Association of Common Polymorphisms in the Nicotinic Acetylcholine Receptor Alpha4 Subunit Gene with an Electrophysiological Endophenotype in a Large Population-Based Sample.
PLoS One
2016
25035082
XRCC5 as a risk gene for alcohol dependence: evidence from a genome-wide gene-set-based analysis and follow-up studies in Drosophila and humans.
Neuropsychopharmacology
2015
26419366
High-throughput screening identified inherited genetic variations in the EGFR pathway contributing to skin toxicity of EGFR inhibitors.
Pharmacogenomics
2015
26258132
Genetic Geostatistical Framework for Spatial Analysis of Fine-Scale Genetic Heterogeneity in Modern Populations: Results from the KORA Study.
Int J Genomics
2015
26521924
Gene regulatory biomarker identification for skin toxicities induced by EGFR inhibitor treatment.
Int J Clin Pharmacol Ther
2015
25943212
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study.
Pharmacogenomics
2015
25533491
Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study.
Lancet Respir Med
2015
24857781
Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients.
Eur J Cancer
2014
22472876
A mega-analysis of genome-wide association studies for major depressive disorder.
Mol Psychiatry
2013
23933821
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.
Nat Genet
2013
23739559
Familial aggregation of pure tone hearing thresholds in an aging European population.
Otol Neurotol
2013
23459588
αCaMKII autophosphorylation controls the establishment of alcohol drinking behavior.
Neuropsychopharmacology
2013
23352970
Investigation into mechanisms mediating the inhibitory effect of 1,4-benzodiazepines on mast cells by gene expression profiling.
Life Sci
2013
22921522
Genome-wide association data provide further support for an association between 5-HTTLPR and major depressive disorder.
J Affect Disord
2013
21747397
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe.
Mol Psychiatry
2012
22949513
Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32.
Hum Mol Genet
2012
22944714
Cluster-localized sparse logistic regression for SNP data.
Stat Appl Genet Mol Biol
2012
23010768
Genome-wide significant association between a 'negative mood delusions' dimension in bipolar disorder and genetic variation on chromosome 3q26.1.
Transl Psychiatry
2012
22874378
IT behind a platform for Translational Cancer Research - concept and objectives.
Stud Health Technol Inform
2012
22004471
Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster.
Addict Biol
2012
21353194
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder.
Am J Hum Genet
2011
21521423
The German multi-centre study on smoking-related behavior-description of a population-based case-control study.
Addict Biol
2011
21750470
Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype.
Pharmacogenet Genomics
2011
20023658
Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate.
Nat Genet
2010
1 - 50 of 77
Column Actions
Search
Recommended Authors
Berta Almoguera
Center for Biomedical Research in Rare Diseases Network
Career Start Year
2010
Number of shared co-authors
11
Liping Hou
Harrison International Peace Hospital
Career Start Year
2009
Number of shared co-authors
80
Alberto Malovini
IRCCS Istituti Clinici Scientifici Maugeri
Career Start Year
2007
Number of shared co-authors
4
Hongsheng Gui
Behavioral Health Services
Career Start Year
2007
Number of shared co-authors
6
Ali Torkamani
Scripps Science Institute
Career Start Year
2005
Number of shared co-authors
17
Sarah S Murray
University of California San Diego Health System
Career Start Year
2004
Number of shared co-authors
72
Steven J Schrodi
University of Wisconsin Madison
Career Start Year
2004
Number of shared co-authors
3
Christian M Shaffer
Vanderbilt University
Career Start Year
2004
Number of shared co-authors
23
Martina M??ller-Nurasyid
Institute for Medical Information Processing
Career Start Year
2003
Number of shared co-authors
51
Scott J Hebbring
Marshfield Clinic Research Institute
Career Start Year
2003
Number of shared co-authors
10
Alison A Motsinger-Reif
National Institute of Environmental Health Sciences
Career Start Year
2002
Number of shared co-authors
8
Gregory D Jenkins
Mayo Clinic
Career Start Year
2001
Number of shared co-authors
11
Marylyn D Ritchie
Center for Systems Genomics, Pennsylvania State University, University Park
Career Start Year
2001
Number of shared co-authors
51
Albert Rosenberger
University of Goettingen
Career Start Year
2001
Number of shared co-authors
21
Yuki Bradford
University of Pennsylvania
Career Start Year
2001
Number of shared co-authors
28
Ilja M Nolte
University of Groningen, University Medical Center Groningen
Career Start Year
2000
Number of shared co-authors
48
Jo Knight
Data Science Institute and Lancaster University Medical School
Career Start Year
2000
Number of shared co-authors
66
Taimour Y Langaee
Center for Pharmacogenomics and Precision Medicine, University of Florida
Career Start Year
1998
Number of shared co-authors
6
Yi-Ju Li
Duke University School of Medicine
Career Start Year
1998
Number of shared co-authors
6
Unnur Thorsteinsdottir
University of Iceland
Career Start Year
1995
Number of shared co-authors
74
David B Goldstein
Institute for Genomic Medicine, Columbia University Irving Medical Center
Career Start Year
1992
Number of shared co-authors
49
Panos Deloukas
William Harvey Research Institute, Queen Mary University of London
Career Start Year
1992
Number of shared co-authors
71
Heike Bickeb??ller
University Medical Center Goettingen
Career Start Year
1992
Number of shared co-authors
65
Andrew A Hicks
Institute for Biomedicine, Affiliated institute of the University of Lubeck
Career Start Year
1990
Number of shared co-authors
44
Russell A Wilke
University of South Dakota Sanford School of Medicine
Career Start Year
1989
Number of shared co-authors
7
Pak C Sham
the University of Hong Kong
Career Start Year
1989
Number of shared co-authors
82
Yudi Pawitan
Karolinska Institute
Career Start Year
1988
Number of shared co-authors
21
Peter Kraft
Harvard T. H. Chan School of Public Health
Career Start Year
1988
Number of shared co-authors
58
Konstantin Strauch
German Research Center for Environmental Health, Institute of Genetic Epidemiology
Career Start Year
1986
Number of shared co-authors
59
Daniel J Schaid
Mayo Clinic
Career Start Year
1982
Number of shared co-authors
12
row(s) 1 - 30 of 30
Collaborators
Markus M N??then
Institute of Human Genetics, University Hospital Bonn
Co-authored papers
18
Catharina Scholl
Federal Institute for Drugs and Medical Devices (BfArM)
Co-authored papers
16
Sven Cichon
University Hospital Basel and University of Basel
Co-authored papers
16
Stefan Herms
Institute of Human Genetics, University of Bonn
Co-authored papers
14
Marcella Rietschel
Central Institute of Mental Health, University of Mannheim
Co-authored papers
12
Manuel Mattheisen
Dalhousie University
Co-authored papers
11
Wolfgang Maier
University Hospital Bonn
Co-authored papers
11
H-Erich Wichmann
Co-authored papers
11
Per Hoffmann
Institute of Human Genetics, University of Bonn and University Hospital Bonn
Co-authored papers
9
Jens Treutlein
Heidelberg University
Co-authored papers
9
Bertram M??ller-Myhsok
Max Planck Institute of Psychiatry
Co-authored papers
9
Josef Frank
Central Institute of Mental Health, Heidelberg University
Co-authored papers
8
Franziska Degenhardt
University of Duisburg-Essen
Co-authored papers
8
Stefan Schreiber
Co-authored papers
8
Ren?? Breuer
Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University
Co-authored papers
7
Jana Strohmaier
Central Institute of Mental Health, University of Heidelberg
Co-authored papers
6
Thomas G Schulze
SUNY Upstate Medical University
Co-authored papers
6
Thomas W M??hleisen
Institute of Neuroscience and Medicine (INM-1), Research Center Juelich
Co-authored papers
5
Thomas Meitinger
Technical University of Munich, Institute of Human Genetics
Co-authored papers
5
Peter Propping
Instituto de Genetica Humana, Universidad de Bonn
Co-authored papers
5
Matthias Schwab
and of Biochemistry and Pharmacy, University of Tuebingen
Co-authored papers
5
Grant W Montgomery
Co-authored papers
5
Susanne Moebus
Co-authored papers
5
Nicholas G Martin
Co-authored papers
5
Nick Craddock
Co-authored papers
4
Michael C O'Donovan
Co-authored papers
4
Jeroen R Huyghe
Co-authored papers
4
Kerstin U Ludwig
Institute of Human Genetics, University of Bonn
Co-authored papers
4
Peter Lichtner
Co-authored papers
4
Christian Gieger
German Research Center for Cardiovascular Disease (DZHK)
Co-authored papers
4
1 - 30